Furthermore, the subretinal fibrosis models in our study showed higher expression levels of the target genes at the GATA5 locus including LAMA5, MTG2, and COL9A3. Clinically, fibrosis is known to be an important predictor of vision outcomes, following anti-VEGF treatment62–64. The gene discussed is COL9A3; the disease is fibrosis.